Industry figures with world-wide expertise in the relevant therapeutic area or market niche provide their opinions of the novel technology:

• In the context of the current commercial climate;
• Providing the views of the market leaders;
• Describing the type of data likely to result in commercial interest in the intellectual property.
  

The discussions frequently result in ongoing communication between research teams and potential licensees of their technology outwith Consolida's involvement in the project.